Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Take a look here, target 10p, easy money to be made.
Guys, take a look at #PANR target £1 and currently 21p, easy money to be made 👍
Certainly going to go from strength to strength now after a big "wobblw".. More news to drop anytime reading through the RNS's !
This company is in the right place at the right time.
Acker
In a nutshell they use mathematical modelling and A.I to see how drugs in use and drugs in development will be effective in treating certain cancers, they have a range of over 70 clients and have proven track record in getting drugs through the various development phases which hitherto have been hit and miss wjrh average drug to marker taking 10 years and 90%failure rate with wasted spend of $$mlns
Q: What competitive advantage does Physiomics have?
That’s a great question. We have several. On the one hand, we are a specialist in oncology mathematical modelling, and there are few companies out there that can say that with their hand on heart. We have competitors that do mathematical modelling who tend to be generalists. We have competitors that focus on oncology, but they don’t tend to be specialists in modelling. So I believe the confluence of those two things is a position where we have a unique market opportunity. The second thing I would say is our people and our experience are really second to none. They work hard, they’re smart and they’re universally well respected by the clients that we take on. I also believe that we’re making genuinely important contributions to the R&D efforts of the clients that that we work with, and that has led to a significant boost in our reputation.
When I arrived at the Company 5-6 years ago, we were fairly little known other than amongst a small circle of clients that we’d been working with for a while. Now we’re getting referrals; people that we work with, talk to their friends and literally relatives sometimes, and we get phone calls from those individuals who may be working in in other companies. We’ve had several projects commissioned in this way, and this is extremely gratifying. I think it’s a real demonstration that what we do makes a difference and that our clients continue to value that.
They tweeted this yesterday which is a new & positive step for them, yes only a "news letter" but at least they are doing something proactive.
https://twitter.com/Physiomics/status/1699363223315607831?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet
Would be interesting to see what the ratio of signups are between those working in biotech and investors.
Amica, i believe Laura is doing a write up, so do not wish to step on their toes.
Re competition if you look at this site, it gives a few names https://craft.co/physiomics/competitors but i am not sure if they are correct!
SP is volatile imho because of it low shares in issue, and free float being really small. We have recently gone from 97m o 135m. It is also news driven, when news lands, be it good or bad, the SP can shift either way quickly.
You mentioned the drop, which one! We had a drop in Feb after CEO said there was some delays to contracts, however, Merckgroup have come back in to the fold, and i believe 1 of the delayed contracts was signed last week (125k)
The other big drop was its epic rise from 1p to 32p, and all the way back again over a period of time. From knowledge the company had to issue a RNS about the contract that was won and its price ( i think )
I am sure Laura will put more meat on the bones.
Looks like the 1.3m trade was a sell. price at time was 2.5/2.6 yesterday
Well it was inevitable. Up for 4 days, which itself has not happened for years.
It nearly got back to parity after falling 10%. Does seem the 2.60p area has a lot of resistance.
18% down and it could have been a lot worse. Fibs were saying 30% retrace before bounce?
what is a surprise is that the spread is approx 4-5% thru the day, i know at one stage it was higher when at 2.3-2.6, but normally the spread is 10% or more, i find this encouraging, i also wonder if that is because there are a few more shares in issue?
Yes Ralph, emerging to top tier just about encapsulates the whole market!
Https://uk.linkedin.com/in/peter-sargent-718085a
Last sentence interesting, (emerging to top-tier).
About
A senior life sciences professional with extensive commercial, scientific, operational and leadership expertise within drug and diagnostic development. Significant experience spanning the full breadth of R&D, as well as leading commercial and operation strategy in high growth businesses and governmental organisations. Now working within a management consultancy practice supporting biopharma (emerging to top-tier) across their R&D with organisation, process and technology transformation.
Some profit taking was inevitable
Clarets
You from Bly or a fan ?
It will be good to see it when those who have turned on q sixpence or gone quiet realise the big rise is only just starting
£3mln market cap /2.4p is so incredibly undervalued
Shares rarely keep going up day in day out,time for a breather and some profit taking! If the good news keeps coming the share price will follow!
I was in POS from 3p ,it did go to 17p in a straight line,I staged up and each mew stage took it higher
It will be great went news lands and PYC goes to the best higher level
Laura. Not sure how old you are but you need to watch some Monty python sketches from you tube cause I note that the BBC and all the other politically correct channels have banned them. As z start watch "the life of Brian " which attacks the trivial Jewish religion which we xll know is trivial and progress your mind from there and search for the "arab" sketch from the 60s where your averzge Arab can live on a grain of rice. Your problem is you are too self righteous. I am Welsh and have put up with crap all my life for a stupid Welsh accent and sheep sh@@@@@ing so please don't come here with hour self righteous politically correct crap. Take a chill pill. Ive done it for 50 years
Need to all calm down. Today hasnt been the day most of us wished but Laura and Kid have spent a lot of time researching PYC and have been a great knowledge base on this bb. Come on lets get behind Pyc and make this one of the better bb on lse.
Laura. I don't care. Report me. I will just appear as someone else. First time I've noticed you've ever responded to me despite me praising you left right and centre. No doubt you are a politically correct Tory
how do the mms get away with posting a delayed trade from yesterday dinnertime. corrupt barstools. no idea if 1.3 million trade is a biy or sell. mms taking the ****.
Well said Stephen Fry Up. You should bevable to make money on aim as an investor and not a mindless ramper or deramper. Time will tell but Physiomics are in a far better place than a few weeks ago. Hope tomorrow is a better day.
Not sure how we've been screwed ? It's simple market mechanics. Bound to be some profit taking after such a rise and a drop before the next leg up. So funny to watch how people change their tune on a day to day basis. The telegram group was ramping away, now those same people are deramping. Hilarious to watch people playing games, aim is the wild West after all. If people are genuine holders here they will be delighted by the past week, even if some are still down on their original investment.
Strange posts and contributions from some people today, some who have gone full circle
Very odd
Belter ! Haha
Fryup before you post, do your homework, last time I posted here was January 2022
Looking ugly now....MMs dropping it too easily